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ABSTRACT
Objectives Abdominal fat has been identified as a risk 
marker of cardiometabolic disease independent of overall 
adiposity. However, it is not clear whether there are ethnic 
disparities in this risk. We investigated the associations of 
visceral adipose tissue (VAT) and abdominal subcutaneous 
adipose tissue (SAT) with cardiometabolic risk factors 
in three ethnic diverse populations of Inuit, Africans and 
Europeans.
Design Cross- sectional pooled study.
Setting Greenland, Kenya and Denmark.
Methods A total of 5113 participants (2933 Inuit, 
1397 Africans and 783 Europeans) from three studies 
in Greenland, Kenya and Denmark were included. 
Measurements included abdominal fat distribution 
assessed by ultrasound, oral glucose tolerance test, 
hepatic insulin resistance, blood pressure and lipids. 
The associations were analysed using multiple linear 
regressions.
Results Across ethnic group and gender, an increase in 
VAT of 1 SD was associated with higher levels of hepatic 
insulin resistance (ranging from 14% to 28%), triglycerides 
(8% to 16%) and lower high- density lipoprotein cholesterol 
(HDL- C, −1.0 to −0.05 mmol/L) independent of body mass 
index. VAT showed positive associations with most of the 
other cardiometabolic risk factors in Inuit and Europeans, 
but not in Africans. In contrast, SAT was mainly associated 
with the outcomes in Inuit and Africans. Of notice was that 
higher SAT was associated with higher HDL- C in African 
men (0.11 mmol/L, 95% CI: 0.03 to 0.18) and with lower 
HDL- C in Inuit (−0.07 mmol/L, 95% CI: -0.12 to –0.02), 
but not in European men (−0.02 mmol/L, 95% CI: −0.09 
to 0.05). Generally weaker associations were observed 
for women. Furthermore, the absolute levels of several of 
the cardiometabolic outcomes differed between the ethnic 
groups.
Conclusions VAT and SAT were associated with several 
of the cardiometabolic risk factors beyond overall 
adiposity. Some of these associations were specific to 
ethnicity, suggesting that ethnicity plays a role in the 
pathway from abdominal fat to selected cardiometabolic 
risk factors.
INTRODUCTION
The last few decades of research have estab-
lished abdominal adipose tissue as a key 
factor and driver of the health risk related 
to overweight and obesity.1 Visceral adipose 
tissue (VAT) has been identified as the 
more pathogenic depot contributing to the 
metabolic consequences of obesity both in 
cross- sectional and longitudinal studies,2–4 
whereas abdominal subcutaneous adipose 
tissue (SAT) has been linked with detri-
mental effects less consistently,2 5 and may 
even be protective.6 In addition, studies have 
found that the relative distribution of VAT 
and SAT varies across ethnic groups and 
suggested that this might explain differences 
in cardiometabolic disease between popula-
tions.7 8 Studies suggest that African ancestry 
populations have less VAT than Europeans8 9 
whereas Asians have been found to be more 
prone to VAT accumulation at lower body 
mass index (BMI) values.10 The impact of 
VAT and SAT on cardiometabolic health has 
been examined in several ethnic populations 
Strengths and limitations of this study
 ► This study analysed the cardiometabolic risk related 
to visceral and subcutaneous abdominal fat in indig-
enous populations in Greenland and Kenya where 
the knowledge is scarce.
 ► We assessed abdominal fat using ultrasound, which 
is a low cost and accessible field method to be used 
on a large scale in logistic challenging settings.
 ► Missing data was handled using multiple imputation 
reducing the likelihood of bias.
 ► The cross- sectional design means that we cannot 
draw causal conclusions about the associations of 
abdominal fat and cardiometabolic risk.
 ► We did not have comparable information on dietary 
factors across the studies.
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including Chinese, Hispanics, South Asians, Canadian 
Aboriginals and African ancestry populations,3 4 7 9 11 12 
with some studies showing ethnic differences in the trend 
of the associations,9 11 12 and others showing similar trends 
across ethnic groups.3 4 7 Thus, it is not clear whether 
abdominal fat is associated differently with cardiometa-
bolic risk factors beyond ethnic differences in absolute 
values of VAT and SAT. Neither is the effect of abdom-
inal fat on cardiometabolic risk fully understood in all 
ethnic groups. However, considering the global burden 
of diabetes and cardiovascular disease (CVD) and rapidly 
changing countries with economic growth and changing 
life conditions in some parts of the world, this knowledge 
becomes increasingly important.
We recently showed ethnic differences in VAT and SAT 
in relation to simple anthropometric measures such as 
BMI and waist circumference in a population of Inuit, Afri-
cans and Europeans.13 Inuit and Africans had lower levels 
of VAT and SAT for a given level of the anthropometric 
measures compared with Europeans, with most consider-
able differences in VAT at higher levels of the anthropo-
metric measures. Inuit and European women, however, 
had similar SAT levels for a given BMI. Whether these 
results suggest that Inuit and Africans are less affected by 
VAT and/or SAT than Europeans, and to which extent 
this accounts for differences in cardiometabolic health 
between these populations needs to be clarified. Based 
on these findings, we aimed to examine whether VAT and 
SAT were associated differently with cardiometabolic risk 
factors in Inuit, Africans and Europeans.
MATERIALS AND METHODS
Study population
This study was based on pooled data from three cross- 
sectional studies (the Inuit Health in Transition Study, 
the Kenya Diabetes Study and Health2008) as described 
in our previous study.13 In brief, the Inuit Health in 
Transition Study was a geographically representative, 
population- based study among Inuit (18+ years) in 
Greenland conducted in the period 2005 to 2010.14 We 
included 3083 participants with clinical examinations and 
Inuit ethnicity based on self- identification and the partic-
ipant’s language. The Kenya Diabetes Study was carried 
out as an opportunistic sample among three rural popula-
tions (Luo, Kamba and Maasai) and an urban population 
in Nairobi of mixed ethnicity from 2005 to 2006.15 A total 
of 1397 participants (17+ years) completed the clinical 
examination. The Health2008 study was a population- 
based study among 795 healthy Danes (30 to 60 years 
old) living in the western part of Copenhagen from 2008 
to 2009.16 Participants who showed up non- fasting for 
examination were excluded (n=162) in the current anal-
yses resulting in a final sample of 5113 individuals (see 
online supplementary figure 1). All participants provided 
written informed consent or oral in case of illiteracy in 
the Kenya Diabetes Study. The studies were performed 
according to the Helsinki Declaration.
Measurements
Anthropometrics and ultrasonography
Height and weight were measured with the participants 
in light clothing and without shoes. Waist circumference 
was measured midway between the iliac crest and the 
rib cage on the standing participant. Ultrasonography 
was used to measure VAT and SAT based on a validated 
protocol.15 17–19 The measures were carried out with a 
portable ultrasound scanner (Pie Medical) using a 3.5 
MHz transducer with the participant lying on their back. 
VAT was the distance in centimetre from the peritoneum 
to the front of the lumbar spine and SAT was the depth in 
centimetre from the skin to the linea alba.
Glucose homoeostasis markers
A 75 g oral glucose tolerance test (OGTT) was performed 
after a minimum of 8 hours of fasting in participants 
without medical treatment for diabetes. Blood samples 
were collected at fasting and 2 hours after the test for the 
measurement of glucose and insulin. In Inuit Health in 
Transition and Health2008 plasma glucose were anal-
ysed by the hexokinase/G6P- DH method.14 16 In Kenya 
Diabetes Study whole blood glucose was analysed by the 
glucose dehydrogenase method on a HemoCue B- Glucose 
201+ device.20 The measures were converted to fasting 
plasma glucose (×1.12) to be comparable with the other 
studies. Serum insulin was measured by an AutoDELFIA 
using fluoro- immunoassay in all three studies. Plasma 
glucose and serum insulin were in all three studies anal-
ysed in the same laboratories at Steno Diabetes Center in 
Gentofte, Denmark. Homoeostasis model assessment for 
insulin resistance (HOMA- IR) was calculated as (fasting 
plasma glucose (mmol/L) × fasting plasma insulin 
(pmol)/6.945)/22.5.21
Cardiovascular risk factors
Blood pressure (BP) was measured at the right arm of 
the sitting participant after at least 5 min of initial rest 
using an automatic mercury sphygmomanometer (Kivex 
UA-779 in the Inuit Health in Transition Study, Mercuro 
300, Speidel & Keller in Health2008 and Omron M6, 
HEM-7001- E, Kyoto, Japan in the Kenya Diabetes Study). 
BP was read three times in the Inuit Health in Transition 
Study with the two last measures averaged.14 Two read-
ings were done in Health2008 and if systolic BP ≥140 mm 
Hg or diastolic BP ≥90 mm Hg, the measurements were 
repeated twice at the same visit. The two lowest values 
were used and averaged.18 In the Kenya Diabetes Study 
two measures were performed and a third, if systolic or 
diastolic BP differed by more than 5 mm Hg. Mean BP was 
calculated from the two lowest measurements.22 Plasma 
total cholesterol, high- density lipoprotein cholesterol 
(HDL- C) and triglycerides were analysed from fasting 
blood samples by enzymatic tests using a Hitachi 912 
system. Low- density lipoprotein cholesterol (LDL- C) was 
calculated from these.14 16 22 Lipid concentrations were 
analysed at Steno Diabetes Center in Gentofte, Denmark, 
for all three studies.
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Covariates
Demographic and behavioural factors were obtained 
from questionnaires. Smoking was coded as current 
smoker or non- smoker. Current medical treatment 
for diabetes, hypertension and dyslipidaemia was 
reported. Classification as Inuit, African or Euro-
pean was done according to Bhopal using the concept 
ethnicity defined as “the group a person belongs to as 
a result of a mix of cultural factors including language, 
diet, religion and ancestry”.23 Physical activity was 
measured objectively using a combined accelerom-
eter and heart rate monitor (Actiheart, CamNTech, 
Cambridge, UK) following the same protocol as previ-
ously described.24–26 Physical activity energy expen-
diture (PAEE) was calculated as kJ/kg/day, and only 
valid recordings >24 hours were included. The blood 
samples in the Inuit Health in Transition Study were 
genotyped and the Inuit- specific TBC1D4 variant 
(Arg684Ter) associated with insulin resistance was 
identified.27 Participants were coded as either non- 
carrier, heterozygous or homozygous carriers, and 
non- carrier status was assumed for participants in the 
Kenya Diabetes Study and the Health2008.
Statistical analyses
Missing data was imputed using Multivariate Imputations 
by Chained Equations (MICE) in R software with missing- 
at- random assumptions.28 Data were imputed from as 
many variables as possible to increase the probability 
that missing values depend on observed data only.29 The 
ultrasound measures had together 4% missing values and 
PAEE 36% missing. Fifty data sets were imputed to get 
sufficiently precise estimates of imputation variability and 
thus valid inference.29 A mean estimate of the relevant 
parameters was averaged across the 50 copies, and SEs 
and p values were computed after Rubin’s rules.30
Multiple linear regression analyses were performed 
with the continuous cardiometabolic variables as func-
tions of VAT and SAT. VAT and SAT were standardised 
to a mean of 0 and a SD of 1 for the pooled sample to be 
able to compare the effects. Outcomes with skewed resid-
uals were log- transformed (HOMA- IR and triglycerides) 
and results presented as percentwise change. All models 
were adjusted for age, age2, smoking, PAEE and BMI. SAT 
was included in the models with VAT and vice versa. Age2 
was included to improve model fit because changes in 
body fat increase rapidly with age. Models with glucose 
homoeostasis outcomes were additionally adjusted for 
the TBC1D4 Arg684Ter variant in Inuit. Non- linearity 
was tested and examined graphically, and linearity was 
assumed for all models. Test for interactions between 
ethnicity and VAT and SAT were done in the pooled study 
sample using the likelihood ratio test.
The associations were examined graphically stratified 
by sex and ethnicity and predicted for median values of 
the covariates (43 years, PAEE of 54 kg/kJ/day, smoker, 
TBC1D4 non- carrier, BMI of 25 kg/m2 and VAT or SAT 
of 0 SD). Participants on glucose- lowering (n=57), 
blood pressure- lowering (n=501) or lipid- lowering drugs 
(n=171) were excluded in the analyses with the corre-
sponding outcomes. Thus, the sample sizes vary for the 
outcomes. Data management was performed in SAS V.9.4 
(SAS Institute, Cary, North Carolina, USA), and statistical 
analyses and graphics in R V.3.2.3 (The R Foundation for 
Statistical Computing, www. r- project. org).
RESULTS
Characteristics of the population are shown in table 1. 
The highest median values of VAT and SAT were observed 
in Europeans among men and in Inuit among women. 
Overall, the Africans were younger, more physically active 
and correspondingly had a better cardiometabolic profile 
than the Inuit and Europeans.
Among men, higher VAT was associated with higher 
levels of HOMA- IR, triglycerides and lower HDL- C across 
all ethnic groups after adjustment for confounders and 
independently of BMI (table 2). For example, 1 SD 
increase in VAT was associated with a 28% (95% CI: 19 
to 37) higher HOMA- IR in European men versus 15% 
(95% CI: 10 to 20) in Inuit men versus 25% (95% CI: 15 
to 35) in African men. Positive associations were found 
between VAT and most of the other cardiometabolic risk 
factors in Inuit and Europeans, but weak and statistically 
insignificant associations were observed in Africans. The 
same pattern was seen in women although with weaker 
associations. Adjustment for BMI generally attenuated 
the associations; however, the directions remained the 
same (see online supplementary table 1 - table 1 without 
adjustment for BMI).
An increase in SAT of 1 SD was associated with higher 
levels of all the cardiometabolic risk factors in African 
men, except fasting glucose, and several in Inuit men 
(diastolic BP, LDL- C and lower HDL- C and fasting 
glucose) (table 2). Similar but weaker associations were 
found in Inuit and African women. SAT only showed 
significant positive associations with HOMA- IR in Euro-
pean men and HOMA- IR, LDL- C and triglycerides in 
European women. Removing the TBC1D4 Arg684Ter 
variant from the analyses showed similar estimates for the 
associations of VAT and SAT with glucose homoeostasis 
outcomes (results not shown).
For VAT, only the association with HDL- C had a signif-
icant ethnicity interaction (figure 1), while several signif-
icant interactions between ethnicity and SAT were found 
with generally steeper associations in African men. For 
example, per 1 SD increment in SAT, systolic BP increased 
with 5.9 mm Hg (CI 95%: 2.49 to 9.32) in African men, 
while no significant associations were found for Inuit 
(1.68 mm Hg, CI 95%: −0.11 to 3.46) and European men 
(−0.42 mm Hg, CI 95%: −2.92 to 2.09). Furthermore, of 
notice was that higher SAT was associated with higher 
HDL- C in Africans and with lower HDL- C in Inuit but not 
significantly in Europeans (figure 1).
Besides differences in the slopes, ethnic differences 
were found for the adjusted absolute levels of several of 
the outcomes for a given VAT and SAT level (see online 
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supplementary figures 2–5). Inuit generally had higher 
absolute levels of total cholesterol, LDL- C and HDL- C 
and Africans the lowest levels. Africans also had lower 
fasting glucose compared with the other groups, but 
markedly higher 2 hour glucose levels were found in 
African men.
DISCUSSION
Summary of findings
The main findings of this study of Inuit, Africans and 
Europeans are that VAT and SAT were associated with 
several cardiometabolic risk factors across the ethnic 
groups independently of each other and BMI. Ethnic 
differences were found in the absolute values of several 
of the cardiometabolic outcomes for a given VAT or SAT, 
but the trends in the associations of VAT were similar 
in Inuit and Europeans, and less consistent in Africans. 
In contrast, several ethnic differences in the trends 
were found for SAT, with steeper slopes among African 
men. Weaker associations were generally observed for 
women.
In context of current literature
Although both VAT and SAT have been associated with 
cardiometabolic risk factors in some studies, the evidence 
on associations of VAT remain more robust.2–5 In the 
present study, VAT was generally stronger associated with 
cardiometabolic risk than SAT in Europeans and slightly 
more in Inuit. We included VAT and SAT simultaneously 
in models to adjust for the concomitant variation of the 
other adipose tissue and thus to get the independent 
effect of VAT and SAT as suggested by Tchernof.1 This 
approach was chosen because in a heterogeneous popula-
tion even simple adiposity measures are almost as strongly 
correlated to cardiometabolic abnormalities as VAT.
VAT was positively associated with several of the 
cardiometabolic risk factors in Inuit and Europeans 
with similar trends, but less consistently so for Africans. 
In contrast, ethnic differences existed for several of 
the associations with SAT, showing steeper associations 
for Africans. In line with our results, a study reported 
stronger associations of SAT than VAT with HOMA- IR 
and the metabolic syndrome in young South African men 
with no effect in women.31 The South African study used 
dual- energy x- ray absorptiometry to measure abdominal 
tissue and adjusted for VAT, SAT and total body fat simi-
larly to ours. The adverse effects of SAT were proposed 
to explain the high prevalence of insulin resistance and 
type 2 diabetes mellitus in African ancestry populations 
despite relatively low VAT levels. Other studies have 
demonstrated similar stronger correlations with insulin 
resistance for SAT than VAT in African ancestry popula-
tions.32 33 In addition, we observed high absolute levels 
of 2 hour glucose in the African men and a strong effect 
of SAT suggesting reduced peripheral insulin sensi-
tivity despite markedly higher levels of physical activity. 
The underlying mechanism and whether it is specific 
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for this African population remains to be determined. 
A possible biological explanation for the associations 
of SAT with several of the cardiometabolic risk factors 
in Africans and in Inuit could be found in morpho-
logical differences between deep and superficial SAT 
layers, which may have distinct metabolic character-
istics.7 For instance, deep SAT has been found to be 
equally correlated to the metabolic syndrome as VAT.34 
Measuring the distinctive SAT layers in future studies 
could contribute to the understanding of the differ-
ences in the metabolic effect of abdominal adiposity in 
these populations.
We generally observed weaker associations for 
women. Sex- related dimorphism in body fat distribu-
tion is well- known35 and it has been suggested that the 
amount of VAT accelerates after menopause in women 
independently of age.36 Thus, it is possible that meno-
pause affects the associations for women and could 
explain the weaker associations. Since information on 
menopause was not collected in all three studies, meno-
pause status was not included in our analyses. However, 
when repeating the predictions for women aged 55 
years assumed to be postmenopausal, the absolute 
levels of 2 hour glucose, total cholesterol and LDL- C 
were similar for European and Inuit women for a given 
VAT and SAT, while no changes were seen for Africans 
and the other outcomes (results not shown). This could 
indicate that menopause plays a role, but to adequately 
assess the impact of menopause on the strength of 
the associations, a longitudinal study with comparable 
information on menopause is required.
Some studies have suggested that populations of 
African ancestry are less prone to accumulate VAT and 
more prone to SAT accumulation.9 37 The African popu-
lation in our study had lower absolute levels of both 
VAT and SAT than the Inuit and Europeans as well as 
Figure 1 Mean values of HDL cholesterol as a function of VAT (upper) and SAT (lower) for each ethnic group in men (left) and 
women (right). The regression lines are predicted for a person with the following values: 43 years, smoker, PAEE level of 54 kJ/
kg/day, BMI of 25 kg /m2, TBC1D4 non- carrier and VAT or SAT of 0 SD. The predictions are shown for the quantile range 5% 
to 95% of VAT or SAT for each ethnic group. P values are for the interaction between ethnicity and VAT or SAT testing the 
hypothesis of parallel lines. BMI,body mass index; HDL, high- density lipoprotein; LDL,low- density lipoprotein; PAEE, physical 
activityenergy expenditure; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.
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a smaller variation. The low values may be caused by 
the fact that it was predominantly a rural population 
with lower VAT and SAT than the urban group reported 
on in a previous study.15 Furthermore, it was a gener-
ally lean population with a high physical activity level. 
Of special notice was that higher SAT was associated 
with higher HDL- C in the Africans and lower HDL- C 
in the two other populations. We cannot rule out that 
this may be a result of the small variation of SAT as well 
as the high positive correlation with BMI, which may 
have reversed the estimated effect of SAT, because of 
the consequently negative correlation of estimates. 
However, the association remained after adjustment 
for BMI. We adjusted for BMI because we wanted to 
examine the effect independently of overall adiposity. 
Waist circumference could have been used as another 
measure of overall adiposity, but since waist circumfer-
ence is highly correlated with VAT and SAT such adjust-
ment yielded multicollinearity in the models. Other 
studies have either adjusted for BMI,11 12 waist circum-
ference12 or both.2 Although similar results are reported 
from analyses where BMI and waist circumferences 
have replaced one another, the various approaches may 
contribute to differences in results between studies. 
It is also likely that HDL- C subclass and/or function, 
rather than the actual concentration of adipose tissue 
plays a role. A recent study from South Africa has shown 
that weight gain and centralisation of fat, in particular 
VAT in black women was associated with no change in 
HDL- C concentrations, but a decrease in large HDL- C 
subtypes.38
African ancestry populations are thought to have 
a healthier lipid profile characterised by lower 
triglycerides and higher HDL- C, which could anticipate 
a lower cardiometabolic disease burden.39 However, a 
higher prevalence of CVD has been found in African- 
Americans compared with Europeans. In this study, 
the Africans had a more beneficial lipid profile and 
worse risk profile for hypertension in line with the 
current evidence, except for low HDL- C. The combi-
nation of a low HDL- C and normal triglycerides has 
been reported in African populations with insulin resis-
tance,40 suggesting that isolated low HDL- C could be 
a major factor in the development of cardiometabolic 
disease in Africans.41 However, a study in South African 
women found lower HDL- C levels and triglycerides in 
black compared with white women, which could not be 
explained by lower VAT or lower insulin sensitivity in 
black women.42 Hence, there may be distinct pathways 
whereby lipids contribute to cardiometabolic risk, which 
varies between African ancestry populations. More-
over, no one in the African population were treated for 
dyslipidaemia and very few for hypertension, which is 
often seen in sub- Saharan African populations43 indi-
cating that either these conditions are undiagnosed, 
untreated or occur less frequently in this African popu-
lation than in migrated African populations. Migrated 
populations may differ from the population of origin 
on several aspects like lifestyle and admixture, which 
could have influenced their cardiometabolic profile.44 
More research that compare African populations living 
in their country of origin with similar ethnic migrated 
populations is needed to better understand the inter-
play between lifestyle, environment and genes in the 
context of urbanisation and changing lifestyles.45
In the Inuit population we found higher absolute 
levels of total cholesterol, HDL- C, LDL- C, blood pres-
sure and lower/similar triglycerides for a given VAT or 
SAT compared with the Europeans. In a previous study 
lower absolute levels of blood pressure, triglyceride, 
2 hour glucose, insulin and higher HDL- C for a given 
BMI and waist circumference level were identified in 
Inuit compared with Europeans, but the trends in the 
associations were the same.46 We extend these findings 
by showing that also VAT had similar trends in the asso-
ciations with cardiometabolic risk factors in Inuit as in 
Europeans even after adjustment for BMI. The differ-
ences in the absolute values were overall consistent with 
the former study but in contrast we found higher blood 
pressure, LDL- C and total cholesterol, pointing in the 
opposite direction. Studies in Arctic Inuit have generally 
demonstrated a favourable lipid profile, but the evidence 
on LDL- C and total cholesterol as well as blood pressure 
is not clear.47 Differences in the results may partly be due 
to differences in the European populations, methods 
and time trends. For instance, it is possible that lifestyle 
changes over time since our first studies in Greenland 
explain the different lipid and blood pressure levels. A 
diet high on n-3 fatty acids and a unique genetic back-
ground have been associated with a beneficial lipid profile 
among Inuit,48 and although the intake of n-3 fatty acids 
has decreased the intake is still high.49 Taken together 
this indicates that both abdominal and overall adiposity 
influence cardiometabolic risk in Inuit and Europeans, 
but differences in the absolute levels of the risk factors 
suggest that other factors than adiposity may explain the 
different cardiometabolic profile in Inuit.
Strengths and limitations
Major strengths of the study are the use of standardised 
ultrasound to assess VAT and SAT, the OGTT to give a 
more detailed picture of glucose metabolism and objec-
tively measured physical activity in such a large population 
and in settings with logistic challenges. Also, comparing 
the three culturally heterogeneous populations with 
extreme differences in lifestyle makes it easier to iden-
tity associations between obesity and cardiometabolic 
health and elucidate ethnic differences. Furthermore, 
multiple imputation of missing values was used instead of 
complete case analyses reducing the likelihood of biassed 
estimates.29
The main limitation of the study is the cross- sectional 
design, not allowing causal relationships to be estab-
lished. The studies were designed and carried out using 
similar protocols; however, some differences in design 
and data collection may still be present. Blood pressure 
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was not measured identically but repeat measurements 
were carried out in all studies minimising the white coat 
effect. VAT and SAT could have been measured more 
detailed with two- dimensional or three- dimensional MRI 
and CT. Although ultrasound is not a guideline- based 
method, the protocol used has been validated against 
MRI and CT in different populations, and was the most 
feasible method in the current large- scale epidemiolog-
ical study.17 50 51 Measures of liver fat could provide more 
insight into the biological mechanisms of the cardiomet-
abolic risk associated with VAT but was not performed in 
all three studies included. Some studies have shown that 
intrahepatic lipid accumulation including non- alcoholic 
fatty liver disease is more detrimental and plays a greater 
role in type 2 diabetes development than VAT,52 and may 
also vary according to ethnicity.8
Furthermore, intra- ethnic and rural/urban differences 
in abdominal fat distribution, insulin resistance and beta- 
cell function has been shown in the African population 
as the Kenya Diabetes Study recruited different ethnic 
groups from rural and urban areas.15 53 These differences 
may be reflected in our results.
Lastly, ethnic differences are a result of an interplay 
between biological mechanisms, genetic and environ-
mental mechanisms. Despite an effort to adjust for 
important confounding factors there will be known and 
unknown factors which we could not take into account, 
for example, we lacked comparable measures of diet 
and alcohol. Especially diet is complex to measure and 
compare across populations, and thus is missing in many 
studies. More studies should elucidate the complexity of 
ethnicity with comparable measures ideally by studying 
populations in the country of origin with migrated 
populations.
CONCLUSION
We showed clinically relevant associations of VAT and 
SAT with several cardiometabolic risk factors in Inuit, 
African and Europeans with ethnic differences. Thus, the 
results support the adverse effect of VAT and SAT beyond 
the effect of overall adiposity. However, the magnitude of 
the effects is not large and significantly different enough 
to propose that VAT (and SAT) is the key driver of differ-
ences in cardiometabolic disease between the included 
populations. The absolute differences in several of the 
cardiometabolic risk factors do, however, imply that the 
groups differ in their underlying adverse or protective 
cardiometabolic profile.
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